Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders
NCT00005893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
OBJECTIVES: I. Determine the efficacy of bone marrow transplantation using matched related donors in patients with nonmalignant hematologic disorders.
II. Determine the quality of life, absence of adverse effects (e.g., graft versus host disease and B cell lymphoproliferative disease), and completeness of recovery of their underlying condition in these patients with this treatment regimen.
Conditions
- Neutropenia
- Sickle Cell Anemia
- Thalassemia Major
- Red-Cell Aplasia, Pure
Interventions
- DRUG
-
anti-thymocyte globulin
- DRUG
-
busulfan
- DRUG
- PROCEDURE
-
Bone marrow transplantation
Sponsors & Collaborators
-
Fairview University Medical Center
lead OTHER
Principal Investigators
-
Paul J. Orchard · Fairview University Medical Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-06-30
Countries
- United States
Study Locations
More Related Trials
-
Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
NCT00208923 ·Status: COMPLETED ·Phase: PHASE2
-
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
NCT04904588 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Stem Cell Transplant for Hemoglobinopathy
NCT00176852 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
NCT00005852 ·Status: TERMINATED ·Phase: PHASE2
-
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
NCT02171104 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
NCT03579875 ·Status: RECRUITING ·Phase: PHASE2
-
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
NCT00253552 ·Status: TERMINATED ·Phase: NA
-
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
NCT00582894 ·Status: COMPLETED ·Phase: NA
-
Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis
NCT00578435 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
NCT00014469 ·Status: COMPLETED ·Phase: PHASE2
-
HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
NCT02793544 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplant for Bone Marrow Failure Syndromes
NCT00176878 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
NCT04644016 ·Status: RECRUITING ·Phase: PHASE2
-
Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
NCT01020734 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
NCT00427661 ·Status: COMPLETED ·Phase: NA
-
Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
NCT00040469 ·Status: TERMINATED ·Phase: PHASE2
-
Pilot Study of Unrelated Cord Blood Transplantation
NCT00916045 ·Status: TERMINATED ·Phase: PHASE2
-
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
NCT00533923 ·Status: COMPLETED ·Phase: PHASE2
-
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
NCT02828592 ·Status: RECRUITING ·Phase: PHASE2
-
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
NCT04965597 ·Status: COMPLETED ·Phase: PHASE2
-
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT03314974 ·Status: RECRUITING ·Phase: PHASE2
-
Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
NCT00004485 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
NCT00857389 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Myeloablative Conditioning and Bone Marrow Transplantation
NCT01850108 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT00004896 ·Status: COMPLETED ·Phase: PHASE2